您当前的位置:
4-Aminobutyric acid. (Synonyms: γ-氨基丁酸; 4-Aminobutyric acid)
目录号: PC15411 纯度: 99%
CAS No. :56-12-2
商品编号 规格 价格 会员价 是否有货 数量
PC15411-5g 5g ¥39.00 请登录
PC15411-25g 25g ¥63.00 请登录
PC15411-100g 100g ¥83.00 请登录
PC15411-500g 500g ¥314.00 请登录
PC15411-2.5kg 2.5kg ¥1307.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
4-Aminobutyric acid.
中文别名
γ-氨基丁酸;gamma-氨基丁酸;4-氨基丁酸;氨酷酸;4(GAMMA)-氨基丁酸;氨酪酸;氨酪酸;伽马氨基丁酸;丁氨酸;4-氨基丁酸;Γ-氨基丁酸;Γ-丁胺酸;四氨基丁酸;r-氨基丁酸;4-Aminobutyric Acid 4-氨基丁酸;4-氨基丁酸(GABA);4-胺基丁酸;y-氨基丁酸;γ-aminobutyric acid; γ-氨基丁酸 标准品;γ-氨基丁酸(GABA);γ-氨基丁酸标准品;γ-氨酪酸;氨基丁酸;并[1,2 -13C2 ] -4 - 氨基丁酸标准品;伽玛氨基丁酸;4-氨基丁酸;γ-Aminobutyric acid;4-氨基丁酸;氨酪酸;4-氨基正丁酸;哌啶酸;γ-氨基丁酸 ​;γ-氨基丁酸,GABA,4-氨基丁酸
英文名称
4-Aminobutyric acid
英文别名
4-Aminobutyric acid;4-AMINOBUTANOIC ACID;4-AMINO-N-BUTYRIC ACID;ALPHA-AMINOBUTANOIC ACID;AMINOBUTYRIC-4 ACID;AMINOBUTYRIC ACID, 4-;AURORA KA-1053;DL-GAMMA-AMINO-N-BUTYRIC ACID;GABA;GAMMA-AMINOBUTYRIC ACID;GAMMA-AMINO-N-BUTYRIC ACID;H-4-AMINOBUTYRIC ACID;H-ABU(4)-OH;H-ABU(GAMMA)-OH;H-GABA-OH;H-GAMMA-ABU-OH;NH2-(CH2)3-COOH;PIPERIDIC ACID;PIPERIDINIC ACID;RARECHEM EM WB 0019;AMINOBUTYRIC ACID, gamma-(GABA)(P);AMINOBUTYRIC ACID, gamma-(GABA)(RG);γ-Aminobutyric acid;Gamma Aminobutyric Acid (GABA);γ-AMinobutanoic acid;3-Carboxypropylamine;γ-aminobutyric acid (GABA);Aminalon;Gammalon;Gaballon;Mielogen;butanoic acid, 4-amino-;Mielomade;Gammalone;Gamarex;Gammasol;Gammar;Reanal;Immu-G;gamma-Aminobutanoic acid;Butyric acid, 4-amino-;Gammagee;Gamastan;Gamulin;4-aminobutyrate;omega-Aminobutyric acid;.gamma.-Aminobutyric acid;gamma-Aminobuttersaeure;4-aminobutanoate;4-amino-butanoic acid;gamma-Amino butyric a
Cas No.
56-12-2
分子式
C4H9NO2
分子量
103.12
包装储存
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
生物活性

γ-Aminobutyric acid (4-Aminobutyric acid) is a major inhibitory neurotransmitter in the adult mammalian brain, binding to the ionotropic GABA receptors (GABAA receptors) and metabotropic receptors (GABAB receptors. γ-Aminobutyric acid shows calming effect by blocking specific signals of central nervous system.

性状

Solid

IC50 & Target[1][2]

Human Endogenous Metabolite

 

Microbial Metabolite

 

体外研究(In Vitro)

γ-Aminobutyric acid (30 μM) depolarizes cortical progenitor cells (E16 cells), results an inward current in ventricular zone (VZ) cells, and induces DNA synthesis inhibition, with half-maximal response concentration of 5 μM.
Cortical plate (cp) neurons expresses glutamic acid decarboxylase (GAD), γ-Aminobutyric acid (1-5 μM; 18 h) stimulates the motility and arrests the migration of cp cells, while the chemotropic signal is involved G-protein activation.
γ-Aminobutyric acid activates GABA A receptors, causing cell cycle arrest in S phase and limiting growth.

Medlife has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Migration Assay

Cell Line: Cortical plate (cp) neurons
Concentration: 1-5 μM
Incubation Time: 18 hours
Result: Promoted motility via G-protein activation and arrested attractantinduced migration via GABAA receptor-mediated depolarization.
体内研究(In Vivo)

γ-Aminobutyric acid (33.95, 102.25, 306.75 mg/kg; p.o.; single dose) can enhance the sleep of mice.
γ-Aminobutyric acid (1, 2, 4 mg/kg/d; p.o.; 30 d) alleviates anxiety and restored food utilization rate in rats, with impairment induced by Di(2-ethylhexyl) phthalate (DEHP) exposure.

Medlife has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Pathogens free (SPF) Bagg’s albino (Balb/c) mice (18–20 g, 8 weeks old)
Dosage: 33.95, 102.25, 306.75 mg/kg
Administration: Oral gavage; single dose; 20 mL/kg administration; measured in an hour
Result: Prolonged the sleep duration, increased sleep rate, and shorten the sleep latency more effectively.
Animal Model: Sprague-Dawley rat indued by DEHP (HY-B1945) (500 mg/kg)
Dosage: 1, 2, 4 mg/kg
Administration: Oral gavage; combined administration; for 30 consecutive days
Result: Reduced the levels of nitric oxide and nitric oxide synthase in rats treated with DEHP.
运输条件

Room temperature or refrigerated transportation.

储存方式
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
结构分类
来源

mammalian central nervous system

参考文献
溶解度数据
体外研究: 

H2O : 50 mg/mL (484.87 mM; Need ultrasonic)

配制储备溶液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 9.6974 mL 48.4872 mL 96.9744 mL
5 mM 1.9395 mL 9.6974 mL 19.3949 mL
10 mM 0.9697 mL 4.8487 mL 9.6974 mL
*

产品不同,其溶解度不同。建议根据产品选择合适的溶剂配制储备溶液;配成溶液后,建议分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C 储存时,建议在 6 个月内使用,-20°C 储存时,建议在 1 个月内使用。

体内研究:

建议根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都建议先按照 体外研究 方式配制澄清的储备液,再依次添加助溶剂:

——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 1.

    建议依照次序添加每种溶剂: PBS

    Solubility: 100 mg/mL (969.74 mM); Clear solution; Need ultrasonic and warming and heat to 60°C

*
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

相关产品

更多
The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2